BRIAN MINKUS: Open Payments
NPI 1235165507 · ARTESIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 24 payments from 11 companies in 2025. Trend: 2023 $281 · 2024 $374 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $96 |
| Amgen Inc. | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $42 |
| Almatica Pharma LLC | 2 | $36 |
| Azurity Pharmaceuticals, Inc. | 1 | $28 |
| Philips North America LLC | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $22 |
Products named: JARDIANCE, Kerendia, AIRSUPRA, OTEZLA, LOREEV XR, FARXIGA, EDARBI, Repatha.
Industry payments across CA — which companies pay providers there.
